Inflammatory processes underlie a broad spectrum of conditions that injure the heart muscle
and cause both structural and functional deficits. In this article, we address current …

Acute renal failure (ARF) severely worsens prognosis of hospitalized patients. The most
frequent cause of intrarenal ARF is transient or prolonged renal hypoperfusion (ischemia) …

Background. White blood cell count to mean platelet volume ratio (WMR) and neutrophil‐to‐
platelet ratio (NPR) have been demonstrated as prognostic inflammatory biomarkers of the …

Cellular damage after reperfusion of ischaemic tissue is defined as ischaemia–reperfusion
injury (IRI). Hypothermia is able to decrease oxygen consumption, preventing a rapid loss of …

Background No-reflow (NR) is the inability to achieve adequate myocardial perfusion
despite successful restoration of attegrade blood flow in the infarct-related artery after …

Several studies have reported the usefulness of inflammatory biomarkers in risk stratification
of ST-elevation myocardial infarction (STEMI) patients. 1, 2 The majority of STEMI occurs as …

Objective The current study was aimed to investigate the involvement of endoplasmic
reticulum stress (ERS)-mediated protein kinase R-like endoplasmic reticulum kinase (PERK) …

Background Hypothermic machine organ perfusion (HMP) offers opportunity to manipulate
grafts with pharmacological agents prior to transplantation. Pretreating organs with novel …

Background To determine the factors affecting the in-hospital prognosis of patients with
acute ST segment elevation myocardial infarction (STEMI) after percutaneous coronary …

Primary percutaneous coronary intervention (PPCI) is the gold standard of treatment in
patients with acute ST-elevation myocardial infarction (STEMI). The no-reflow phenomenon …